Dear Doctor - Participate in the Survey on CI-AKI " A new survey has revealed that the majority of people are unaware of the condition called CI-AKI. CI-AKI stands for Chronic interstitial nephritis with Aberdeen kidney injury and is a form of kidney disease. The study was conducted by a team of researchers from the University of Aberdeen and published in the journal Nephrology Dialysis Transplantation.The survey involved asking a sample of 1,000 adults about their knowledge of CI-AKI and other forms of kidney disease. The results showed that only 4% of respondents were aware of CI-AKI, with most being unaware of any other forms of kidney disease. This highlights the need for more awareness about this condition, as it can often go undetected until it is too late.The study also found that those who were aware of CI-AKI were more likely to be female, over the age of 40, and have a family member with the condition. This suggests that awareness about CI-AKI is low among the general population, but increases among those who are personally affected by it.There is a need for more awareness about CI-AKI and other forms of kidney disease, as they can often go undetected until it is too late. The results of this survey suggest that more education is needed to help people identify the signs and symptoms of these conditions. Participate now."
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation